Pfizer hiked its projections for COVID vaccine revenues, telling investors this week it expects booster shots, a vaccine targeting the Delta variant and anticipated authorization of its vaccines for children as young as 6 months will drive revenues higher.
Israeli researchers found people who received two doses of the Pfizer vaccine were eight times more likely to be infected with the South African variant, and people who received one dose of the vaccine were more likely to get the UK variant.
